Jun 7, 2021 08:05AM
Jun 7, 2021 08:00AM
May 10, 2021 07:35AM
May 10, 2021 07:30AM
May 3, 2021 07:31AM
May 3, 2021 07:30AM
Apr 22, 2021 07:30AM Intra-Cellular Therapies Announces Investor Webcast and Presentations on Lumateperone Programs at the Upcoming American Psychiatric Association (APA) Annual Meeting
Apr 20, 2021 07:00AM
Apr 19, 2021 09:05AM
Apr 12, 2021 07:30AM
Feb 25, 2021 07:30AM
Feb 24, 2021 07:30AM
Feb 22, 2021 08:09AM
Feb 22, 2021 08:00AM Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression
Jan 21, 2021 08:09AM
Jan 21, 2021 08:00AM
Dec 29, 2020 08:01AM
Dec 29, 2020 08:00AM
Dec 9, 2020 08:00AM
Nov 9, 2020 07:30AM
Sep 9, 2020 07:01AM Intra-Cellular Therapies (ITCI) Study 402 Evaluating Lumateperone as Adjunctive Therapy in Patients with Bipolar Depression Met the Primary Endpoint
Sep 9, 2020 07:00AM
Aug 10, 2020 07:30AM
Jun 29, 2020 08:01AM
Jun 29, 2020 08:00AM
May 7, 2020 07:30AM
Apr 2, 2020 08:00AM
Mar 23, 2020 07:30AM Intra-Cellular Therapies Announces Availability of CAPLYTA™ (lumateperone) for Adult Patients with Schizophrenia
Mar 2, 2020 07:31AM
Mar 2, 2020 07:30AM
Feb 20, 2020 05:00PM
Dec 24, 2019 04:36AM
Dec 23, 2019 10:31AM
Dec 23, 2019 10:17AM
Dec 23, 2019 10:16AM Intra-Cellular Therapies (ITCI) IV at 120 after announces FDA approval of CAPLYTA
Dec 23, 2019 08:44AM
Dec 23, 2019 07:36AM
Dec 23, 2019 07:00AM
Dec 23, 2019 06:59AM
Dec 12, 2019 07:31AM
Dec 12, 2019 07:30AM
Dec 4, 2019 08:00AM Intra-Cellular Therapies to Present Data on Lumateperone and ITI-333 at the 58th Annual Meeting of the American College of Neuropsychopharmacology
Nov 5, 2019 07:30AM
Oct 29, 2019 08:00AM
Sep 30, 2019 08:00AM
Sep 25, 2019 07:30AM
Sep 10, 2019 09:11AM
Sep 10, 2019 07:44AM
Sep 10, 2019 07:30AM Intra-Cellular Therapies Provides Lumateperone Regulatory Update
Aug 7, 2019 08:00AM

151,992 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All